| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.NEUROBIOLAGING.2014.07.028 |
| P8608 | Fatcat ID | release_lrc53eyndnc6biyhbzvg6e5r3a |
| P3181 | OpenCitations bibliographic resource ID | 2226842 |
| P932 | PMC publication ID | 4317375 |
| P698 | PubMed publication ID | 25444595 |
| P4011 | Semantic Scholar paper ID | 9a40792fd2d16355b2c7234e3b9481564c7cdf3d |
| P50 | author | John Anthony Hardy | Q6237755 |
| Andrew Singleton | Q4758591 | ||
| Rita Guerreiro | Q20049176 | ||
| Christina M Lill | Q47817873 | ||
| Maria Martinez | Q56827527 | ||
| Francis Walker | Q61152996 | ||
| Thomas Gasser | Q64856147 | ||
| Dena G. Hernandez | Q64856786 | ||
| Michele T M Hu | Q64857486 | ||
| Margaux F Keller | Q64860204 | ||
| Elisa Majounie | Q64860206 | ||
| Peter Heutink | Q66718007 | ||
| Lars Bertram | Q91179371 | ||
| J Raphael Gibbs | Q114270383 | ||
| Connor Edsall | Q125293550 | ||
| Vincent Plagnol | Q28320554 | ||
| Bryan Traynor | Q28777952 | ||
| Sampath Arepalli | Q30089854 | ||
| Daniela Berg | Q30500724 | ||
| Claudia Schulte | Q38323121 | ||
| Nathan Pankratz | Q42577075 | ||
| Jose Bras | Q43132633 | ||
| Alan Renton | Q44478769 | ||
| Anita L DeStefano | Q47502953 | ||
| Hannah Pliner | Q47817868 | ||
| P2093 | author name string | Joyce Y Tung | |
| Mohamad Saad | |||
| Nick Wood | |||
| Margaret Sutherland | |||
| Mike A Nalls | |||
| Nicholas Eriksson | |||
| Janet Brooks | |||
| Steven Lubbe | |||
| Noah Nichols | |||
| Iris Jansen | |||
| Chris Letson | |||
| Tatiana Faroud | |||
| P2860 | cites work | A two-stage meta-analysis identifies several new loci for Parkinson's disease | Q21144948 |
| Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease | Q21144949 | ||
| Potential etiologic and functional implications of genome-wide association loci for human diseases and traits | Q22066284 | ||
| An integrated map of genetic variation from 1,092 human genomes | Q22122153 | ||
| A large study reveals no association between APOE and Parkinson's disease | Q24598836 | ||
| Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies | Q24606055 | ||
| Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study | Q24622472 | ||
| A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis | Q24648667 | ||
| Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease | Q28244731 | ||
| Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease | Q28292932 | ||
| Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy | Q29417026 | ||
| Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1. | Q29417029 | ||
| Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database | Q29417106 | ||
| ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data | Q29547161 | ||
| Integrating common and rare genetic variation in diverse human populations | Q29547220 | ||
| Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease | Q29614879 | ||
| Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease | Q29614881 | ||
| Fast and accurate genotype imputation in genome-wide association studies through pre-phasing | Q29614942 | ||
| Best practices and joint calling of the HumanExome BeadChip: the CHARGE Consortium | Q30418185 | ||
| Measures of autozygosity in decline: globalization, urbanization, and its implications for medical genetics | Q30440042 | ||
| Chromosome 9 ALS and FTD locus is probably derived from a single founder | Q35853974 | ||
| Locus-specific mutation databases for neurodegenerative brain diseases | Q36302037 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | data sharing | Q5227350 |
| neurodegeneration | Q1755122 | ||
| P304 | page(s) | 1605.e7-12 | |
| P577 | publication date | 2015-03-01 | |
| P1433 | published in | Neurobiology of Aging | Q7002141 |
| P1476 | title | NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases | |
| P478 | volume | 36 |
| Q92534876 | A Targeted Gene Panel That Covers Coding, Non-coding and Short Tandem Repeat Regions Improves the Diagnosis of Patients With Neurodegenerative Diseases |
| Q57177625 | A comprehensive analysis of SNCA-related genetic risk in sporadic parkinson disease |
| Q36311348 | A data-driven approach links microglia to pathology and prognosis in amyotrophic lateral sclerosis |
| Q47823702 | A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci. |
| Q33640996 | Additional rare variant analysis in Parkinson's disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance |
| Q28602162 | Baseline genetic associations in the Parkinson's Progression Markers Initiative (PPMI) |
| Q33614811 | C9ORF72 hexanucleotide repeat exerts toxicity in a stable, inducible motor neuronal cell model, which is rescued by partial depletion of Pten |
| Q42145966 | Circulating Cholesterol Levels May Link to the Factors Influencing Parkinson's Risk |
| Q39852415 | Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease |
| Q57291461 | Coding variation in GBA explains the majority of the SYT11-GBA Parkinson's disease GWAS locus |
| Q37572904 | Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype |
| Q37615837 | Discovery and functional prioritization of Parkinson's disease candidate genes from large-scale whole exome sequencing |
| Q38379396 | Epigenetic mechanisms in neurological and neurodegenerative diseases |
| Q36396085 | Evaluating pathogenic dementia variants in posterior cortical atrophy |
| Q50424585 | Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease |
| Q38686112 | Exercise and Nutritional Benefits in PD: Rodent Models and Clinical Settings |
| Q92565228 | Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts |
| Q38674162 | Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases |
| Q36595652 | Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases |
| Q42376263 | Genome-wide assessment of Parkinson's disease in a Southern Spanish population |
| Q90031839 | Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts |
| Q37531688 | HFE p.H63D polymorphism does not influence ALS phenotype and survival |
| Q91183320 | Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies |
| Q38425458 | Inflammation in Parkinson's disease: role of glucocorticoids. |
| Q38376569 | Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease |
| Q51765701 | Multimodal neuroimaging and behavioral assessment of α-synuclein polymorphism rs356219 in older adults. |
| Q34714497 | Mutation analysis of patients with neurodegenerative disorders using NeuroX array |
| Q47902700 | Mutation analysis of sporadic early-onset Alzheimer's disease using the NeuroX array |
| Q38731672 | NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases |
| Q45915163 | Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels. |
| Q92053508 | Parkinson's Disease: The Emerging Role of Gut Dysbiosis, Antibiotics, Probiotics, and Fecal Microbiota Transplantation |
| Q36276040 | Parkinson's disease biomarkers program brain imaging repository |
| Q47338262 | Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program |
| Q53397478 | Pleiotropic Effects of Variants in Dementia Genes in Parkinson Disease. |
| Q47580923 | Polygenic risk score in postmortem diagnosed sporadic early-onset Alzheimer's disease |
| Q26779516 | Predictive Big Data Analytics: A Study of Parkinson's Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete Observations |
| Q37395786 | Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease. |
| Q34538408 | Report of a workshop on research gaps in the treatment of cerebral palsy |
| Q36815405 | Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease |
| Q37501882 | Screening exons 16 and 17 of the amyloid precursor protein gene in sporadic early-onset Alzheimer's disease |
| Q39686532 | Ser(P)-1292 LRRK2 in urinary exosomes is elevated in idiopathic Parkinson's disease |
| Q33576727 | Study protocol: Insight 46 - a neuroscience sub-study of the MRC National Survey of Health and Development |
| Q91798573 | Ten Years of the International Parkinson Disease Genomics Consortium: Progress and Next Steps |
| Q28076121 | The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort |
| Q36777618 | The NINDS Parkinson's disease biomarkers program |
| Q48177216 | The wide genetic landscape of clinical frontotemporal dementia: systematic combined sequencing of 121 consecutive subjects |
| Q92979211 | iPSC modeling of young-onset Parkinson's disease reveals a molecular signature of disease and novel therapeutic candidates |
Search more.